3164 logo

GenMont Biotech Incorporation Stock Price

TWSE:3164 Community·NT$1.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3164 Share Price Performance

NT$16.60
-3.65 (-18.02%)
NT$16.60
-3.65 (-18.02%)
Price NT$16.60

3164 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
1 Reward

GenMont Biotech Incorporation Key Details

NT$401.2m

Revenue

NT$149.6m

Cost of Revenue

NT$251.6m

Gross Profit

NT$194.4m

Other Expenses

NT$57.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.67
62.72%
14.26%
5.2%
View Full Analysis

About 3164

Founded
2000
Employees
n/a
CEO
Yujin Chen
WebsiteView website
www.genmont.com.tw

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

Recent 3164 News & Updates

Recent updates

No updates